Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia

NCT00716274 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder
Dyslexia

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

Eli Lilly and Company